Evidence map›Paper›PMID 16477433›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2006

99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody.

Francis G Blankenberg, Judy Kalinyak, Liping Liu, Maya Koike, Danye Cheng, Michael L Goris, Allan Green, Jean-Luc Vanderheyden, David C Tong, Midori Anne Yenari

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Radionuclide imaging of apoptosis for clinical application.European journal of nuclear medicine and molecular imaging · 2022
    Review
  3. Review
  4. Article
  5. Evaluation ofArthritis research & therapy · 2018
    Article
  6. Annexins in Glaucoma.International journal of molecular sciences · 2018
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Monitoring stroke progression: in vivo imaging of cortical perfusion, blood-brain barrier permeability and cellular damage in the rat photothrombosis model.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2014
    Article
  13. A dual-labeled Annexin A5 is not suited for SPECT imaging of brain cell death in experimental murine stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2014
    Article
  14. Article
  15. Article
  16. Article
  17. Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2012
    Review
  18. Visualization of cell death in mice with focal cerebral ischemia using fluorescent annexin A5, propidium iodide, and TUNEL staining.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2011
    Article
  19. Review
  20. Phosphatidylserine targeting for diagnosis and treatment of human diseases.Apoptosis : an international journal on programmed cell death · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Francis G BlankenbergDivision of Pediatric Radiology/Department of Radiology, Stanford University Hospital, 725 Welch Road, Rm #1673, Lucile Packard Children's Hospital, Palo Alto, CA 94305, USA. blankenb@stanford.edu
Judy Kalinyak
Liping Liu
Maya Koike
Danye Cheng
Michael L Goris
Allan Green
Jean-Luc Vanderheyden
David C Tong
Midori Anne Yenari

Funding

Inflammatory Mechanisms in Cerebral IschemiaR01NS040516 · NINDS · STANFORD UNIVERSITY · PI YENARI, MIDORI A · 2001 to 2014
$4.6M
Imaging Apoptosis in vivo with Technetium 99m AnnexinR01EB000898 · NIBIB · STANFORD UNIVERSITY · PI BLANKENBERG, FRANCIS GERARD · 2003 to 2007
$2.0M
NIBIB NIH HHS EB000898NINDS NIH HHS R01 NS40516
6 · The paper itself

Abstract

purposeThe first aim of the study was to determine whether (99m)Tc-HYNIC-annexin V, a marker of cellular stress and apoptosis, can detect ischemic injury in patients with acute stroke. Secondly, we wished to test radiolabeled annexin's ability to monitor therapy in a rodent model of focal ischemic injury.

methodsSPECT imaging of patients was performed between 1 and 2 h after intravenous injection of 30 mCi (1,110 MBq) of tracer. Eight MFL4 (anti-FasL) antibody-treated (400 microg i.p. days 0 and 3) and 21 control adult male Sprague-Dawley rats underwent small animal SPECT imaging with 5-10 mCi (185-370 MBq) of tracer, 1 and 6 days after a 2-h intraluminal thread occlusion of the left middle cerebral artery.

resultsTwo patients with acute stroke had regions of multifocal annexin uptake that correlated with sites of restricted diffusion on MRI. Anti-FasL antibody treatment significantly reduced annexin uptake by 92% with a 60% decrease in the number of caspase-8 staining (apoptotic) neurons on day 1. On day 6, treated animals had an 80% reduction in tracer uptake with a 75% decrease in infarct size as compared with controls. Annexin uptake in controls and treated animals (day 6) linearly correlated with infarct size (r (2)=0.603, p=0.0036) and the number of TUNEL-positive (apoptotic) nuclei (r (2)=0.728, p=0.00084).

conclusionAnnexin imaging shows foci of increased uptake at sites of ischemic injury in patients with acute stroke. Annexin imaging can assess the effects of therapy for ischemic cerebral injury in rats, suggesting its potential as a non-invasive indicator of drug efficacy in future clinical trials.

Indexed as

Annexin A5Organotechnetium CompoundsAcute DiseaseAnimalsAntibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedBrain IschemiaHumansMaleNeuroprotective AgentsPrognosisRadiopharmaceuticalsRatsRats, Sprague-DawleyReproducibility of ResultsSensitivity and SpecificityAnnexin A5Antibodies, MonoclonalAntibodies, Monoclonal, Murine-Derivedanti-Fas monoclonal antibodyNeuroprotective AgentsOrganotechnetium CompoundsRadiopharmaceuticalstechnetium Tc 99m HYNIC annexin V

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.